the e-cigarettes are the most commonly used drugs in the world. however, the effectiveness of cytisinicline is not well understood. in the last quarter, the e-cigarettes are now being used in the united states for smoking cessation and nicotine addiction. in the last quarter, the development of cytisinicline has been focused on the development of cytisinically administered cytisinicline. in this article, we discuss the main issues that we discuss on the second quarter and discuss the progress of our phase 3 trial designs.